Evidence map›Paper›PMID 29392446›Full record

ReviewCurrent psychiatry reports2018

Psychiatric Aspects of Acute Porphyria: a Comprehensive Review.

Laura Duque-Serrano, Liliana Patarroyo-Rodriguez, Dorothy Gotlib, Juan C Molano-Eslava

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current psychiatry reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Acute psychosis in variegate porphyria: a case report.Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Acute intermittent porphyria: prevalence of pathogenicAnnals of translational medicine · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Therapeutic strategies for acute intermittent porphyria.Intractable & rare diseases research · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Acute hepatic porphyrias.Porto biomedical journal
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Laura Duque-SerranoFundaMental Research Group, Psychiatry and Mental Health Department, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Liliana Patarroyo-RodriguezFundaMental Research Group, Psychiatry and Mental Health Department, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Dorothy GotlibDepartment of Psychiatry, Michigan Medicine, Ann Arbor, MI, USA.
Juan C Molano-EslavaFundaMental Research Group, Psychiatry and Mental Health Department, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia. molanojuan@hotmail.com.
Universidad de Los Andes · COMichigan Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThe aim of this paper is to review psychiatric manifestations, comorbidities, and psychopharmacological management in individuals with acute porphyria (AP). RECENT

findingsRecent literature begins to clarify associations between AP, schizophrenia, bipolar disorder, and other psychopathology. Broad psychiatric symptoms have been associated to acute porphyria (AP) and correspond to a spectrum of heterogeneous manifestations such as anxiety, affective alterations, behavioral changes, personality, and psychotic symptoms. These symptoms may be difficult to identify as being related to porphyria since symptoms may arise at any time during the disease process. In addition, these patients may present psychiatric conditions secondary to the disease, such as adjustment disorder and substance use disorders. Timely diagnosis and appropriate treatment of psychiatric manifestations positively impact the course of the disease.

Indexed as

AnalgesicsAnti-Inflammatory Agents, Non-SteroidalComorbidityHumansMental DisordersPersonalityPorphyria, Acute IntermittentPsychopathologyAnalgesicsAnti-Inflammatory Agents, Non-SteroidalAcute intermittent porphyriaAcute porphyriaConsult-liaison psychiatryMental disordersPersonality traitsPsychosis

Identifiers

PMID29392446
OpenAlexW2794202096

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.